my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Chemokine Therapeutics Corp. announced that it has received a Certificate for Clinical Trial/Medicinal Test from the Hong Kong Department of Health allowing the Company to begin a Phase II trial in liver cancer with its lead drug candidate, CTCE-9908. The Company received FDA and Health Canada appro more
Chemokine Therapeutics Corp. announced that Dr. Andrew Zhu has joined the Company's Oncology Clinical Advisory Board. The Advisory Board plays an important role in guiding the CTCE-9908 clinical development program. Dr. Andrew Zhu is an attending oncologist as well as the director of Liver Cancer R more
Chemokine Therapeutics Corp. announced that Edward Taylor and Walter Korz have joined the Board of Directors. They will fill vacancies created by the resignations of Dr. Hassan Salari and Reza Bahadori. Dr. Salari has also resigned as the Company's part-time Chief Scientific Officer. Mr. Taylor will more
Funxional Therapeutics Ltd SITE MAP CONTACT US HOME ABOUT FXT Business Strategy Management Team Board of Directors Investors Scientific Advisors Business Development SCIENCE & TECHNOLOGY Chemokine Inhibitors ApoE Mimetics GAEL PRODUCTS PIPELINE FX125L FX141L FX87L PRESS ROOM Selected Publications Fa more
Last: 0.425 Day Low: 0.38 Volume: 5571 Change: 0.00 Day High: 0.43 Date: 7/27/2010 Pipeline iCo-007 iCo-008 iCo-009 Clinical Trials Enter Your Email to Sign Up for iCo Therapeutics Updates Pipeline iCo-007 iCo Therapeutics is developing iCo-007, a second generation antisense inhibitor targeting C-ra more
Printable version About us Our Products R & D Partnerships People Investor & Media Goals & Focus Research Programs Patents Scientific Publications Scientific Publications 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 2010 Breton E, Goetz C, Kintz J, Accart N, Aubertin G, Gr more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
